Earl Solomon, DPM
Foot & Ankle Surgery · Marble Falls, TXNPI 1437133915
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (30.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Arthrosurface Incorporated accounts for 86.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $2,977 and has fallen 91.8% since, to $245 in 2025.
Across 35 payments — averaging $142.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrosurface Incorporated$4K
- Stryker$545
- Anika Therapeutics, Inc.$64
- KCI USA, Inc.$23
- Core Surgical Group$18
- Medtronic$14
- plus $14 from 1 others
What the payments were for
- Consulting fees$1,25025%
- Speaking & faculty fees$1,50030%
- Travel & lodging$1,06721%
- Food & beverage$1,16023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrosurface Incorporated | 15 | $4,298 |
| Stryker(2 entities) | 13 | $545 |
| Anika Therapeutics, Inc. | 3 | $64 |
| KCI USA, Inc. | 1 | $23 |
| Core Surgical Group | 1 | $18 |
| Medtronic | 1 | $14 |
| Treace Medical Concepts, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hammertoe Correction System$2,750
- HemiCAP MTP Resurfacing$992
- Toe MotionTM$109
- HemiCAP$109
- Toemate$109
How this compares
$4,977 in reported general payments places this provider in the 55th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 91 | $2,705 |
| Clobetasol Propionate | 15 | $874 |
| Itraconazole | 37 | $799 |
| Pregabalin | 16 | $537 |
| Meloxicam | 50 | $239 |
| Ropinirole Hcl | 17 | $236 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $184 |
| Terbinafine Hcl | 46 | $181 |
| Silver Sulfadiazine | 11 | $130 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 35 | $102 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Marble Falls
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.